News & Events

CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice
A CAR-T-based immunotherapy successfully kills tumors and prevents metastatic growth, in final preclinical tests before human trials.
05/01/18

New Map Defines Areas of Highest Prostate Cancer Burden
To improve the impact of outreach efforts, researchers develop a better way to identify areas with high risk patients
04/26/18

What Learning Looks Like in the Brain
Using advance imaging technology, researchers observe new patterns of molecular organization as connections between neurons strengthen during learning.
04/23/18

New Tool to Study Hospital Readmissions Focuses on Patient Uncertainty
To explore causes of hospital readmissions, researchers created a tool to identify and quantify a patient’s feelings of uncertainty during their initial emergency department visit.
04/23/18

New Tool for Studying the Causes of Intervertebral Disc Degeneration and Back Pain
A new mouse model could help researchers learn about the causes and mechanisms driving lower back pain linked-to invertebrate disc disease.
04/19/18

Improving Surgery for Pelvic Bone Cancers
Computer-aided surgery facilitates complete cancer removal for difficult pelvic tumors
04/16/18

Six Health Systems form Consortium to Expand Access to Clinical Trials
Six regional health systems today announced the founding of a nonprofit clinical research consortium – Partners in Innovation, Education, and Research (PIER Consortium™) – a streamlined clinical trial system that will span New Jersey and Pennsylvania.
04/16/18

Nanoparticles for Lung Cancer Pass Next Test
Non-small cell lung cancer Nanoparticles pass the next stage of development in preclinical tests.
04/10/18

Reducing Odds of Hospital Readmissions with Better Transitions of Care
Patients treated for heart attack were 48 percent less likely to have a sudden return to the hospital when educated using a multi-factored discharge and follow-up program
04/02/18

New Targeted Therapy Schedule Could Keep Melanoma at Bay
Optimizing the timing of targeted therapies for melanoma reverses tumor growth, and resistance can be mitigated
03/26/18